ACIW vs NBIX · P/E 18, rev $856.2M vs P/E 45, rev $1.77B
ACI Worldwide Inc (ACIW) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
ACI Worldwide Inc (ACIW) is a software - infrastructure company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ACIW revenue for 2026-06-30 was $856.2M. Net income was $70.1M. ACIW currently screens at market cap $4.85B and trailing P/E 18.3.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ACIW currently screens at market cap $4.85B and trailing P/E 18.3. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ACIW and NBIX stock pages for the full models.
Not investment advice.